Dr. John Cush RheumNow
3 years ago
Surprising Link Between Weight Gain and RA Activity
In patients with RA treated with infliximab (Remicade), increases in body mass index (BMI) scores over time were not associated with increased disease activity or faster radiographic progression.
https://t.co/hXuJbwiY7B https://t.co/G88CTkSlB5
Dr. John Cush RheumNow
3 years ago
Importance of Diagnostic Imaging in #PMR
Dr. Claire Owen, Melbourne, discusses the importance of imaging to the diagnosis of polymyalgia rheumatica. This is part of a video series produced by RheumNow for its October 2023 campaign, Make Rheum for PMR.
https://t.co/IZAlfcjWDX https://t.co/B5rvy1J140
Dr. John Cush RheumNow
3 years ago
Felson reports a novel model to study knee OA. 2,340 Adults from the MOON study undergoing post-traumatic ACL reconstructions (ACLR), 16-26% identified w/ continued w/ knee pain & at risk for accelerated #OA -->study of interventions https://t.co/rDaNmeCGXM https://t.co/tm0kZ2ax78
Dr. John Cush RheumNow
3 years ago
In 2024, the new Samsung Galaxy watch will be able to detect sleep apnea using the Samsung Health Monitor app that monitors BP, ECG, irregular heart rhythm, and blood O2 levels. Approved by Korea’s Ministry of Food and Drug Safety for use in Korea. https://t.co/ijWNzYWiF5 https://t.co/2nRkgzuYfI
LauraCoates
3 years ago
It's so important to diagnose psoriatic arthritis early. If you have psoriasis please join the HPOS study at https://t.co/xBBFj4npgo https://t.co/qBxDzr2IZZ
In this Tuesday Night Rheumatology webinar, the panel discussed the use of corticosteroids in patients with polymyalgia rheumatica. Panelists: Drs. Lindsay Lally, Richard Conway and Max Yates. Moderated by Dr. David Liew.
It is important to clarify that frailty is not a synonym of age (chronological age). Although there are only a few studies studying the impact of frailty in PMR, frailty is a relevant issue due to several important factors.
Dr. John Cush RheumNow
3 years ago
Electronic survey of US rheumatology fellows assessed burnout in Fellows using Maslach Burnout Inventory. Only 18% (105/582) of ped & adult fellows responded; 38% PGY4s & 17% PGY5/6 had 1+ burnout Sxs. 13% PGY4 fellows met criteria for depression https://t.co/6Bhrpl1LCW https://t.co/99snXAUFa4
Dr. John Cush RheumNow
3 years ago
Long-term Safety of a JAKi in Patients with RA With up to 6.5 Years of Exposure
View this poster on the long-term integrated safety data with a JAKi in patients with RA from 6 clinical studies. Sponsored by AbbVie US Medical Affairs https://t.co/q6Mlr78XFG. https://t.co/neMnFDSRze
This week the CDC's MMWR reports that during 2019–2021, 21.2% of U.S. adults (53.2 million) reported "diagnosed arthritis". And that over half (52.2%–62.4%) of adults with self-reported dementia, chronic obstructive pulmonary disease, stroke, heart disease, diabetes, or cancer also report having been diagnosed with arthritis.
Dr. John Cush RheumNow
3 years ago
Full Read review of #PMR in Lancet:
- Start @ 12·5–25mg prednisone qd
- Remission in most but, relapses in 40–60%
- Onset sudden; AM stiffness predominates; Shoulders>Pelvic
~50% have distal MSK Sxs
- US: look for B/L sub-acromial/deltoid bursitis https://t.co/GJDGjOD7oX https://t.co/nWMW3HB0YK
Dr. John Cush RheumNow
3 years ago
#PMR Mimics: PMR vs RA?
Dr. Robert Spiera (New York) discusses mimics of polymyalgia rheumatica. This is part of a video series produced by RheumNow for its October 2023 campaign, Make Rheum for PMR.
https://t.co/MI06ERq1qI https://t.co/UBhha3DjNa
Dr. John Cush RheumNow
3 years ago
#PMR: glad or bad tidings?
Please don’t tell your patient that PMR “typically” lasts two years. Because it probably won’t last exactly two years, and then they’ll be less inclined to believe other things you say.
Read more...
https://t.co/ET9OPa7yjq
@sarah_L_mackie https://t.co/0axS6AVQV3
